CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 256 filers reported holding CYTOKINETICS INC in Q3 2023. The put-call ratio across all filers is 2.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $75,835,873 | -9.7% | 2,574,198 | 0.0% | 1.60% | +0.1% |
| Q2 2023 | $83,970,339 | -7.3% | 2,574,198 | 0.0% | 1.60% | -15.2% |
| Q1 2023 | $90,586,028 | -23.2% | 2,574,198 | 0.0% | 1.89% | -21.7% |
| Q4 2022 | $117,949,752 | -5.4% | 2,574,198 | 0.0% | 2.41% | -16.2% |
| Q3 2022 | $124,720,000 | +23.9% | 2,574,198 | +0.5% | 2.88% | +10.6% |
| Q2 2022 | $100,629,000 | +6.7% | 2,561,182 | 0.0% | 2.60% | +33.3% |
| Q1 2022 | $94,277,000 | -19.2% | 2,561,182 | 0.0% | 1.95% | +14.4% |
| Q4 2021 | $116,739,000 | +63.3% | 2,561,182 | +28.1% | 1.70% | +58.2% |
| Q3 2021 | $71,480,000 | +80.6% | 2,000,000 | 0.0% | 1.08% | +80.6% |
| Q2 2021 | $39,580,000 | -14.9% | 2,000,000 | 0.0% | 0.60% | -17.8% |
| Q1 2021 | $46,520,000 | +12.6% | 2,000,000 | 0.0% | 0.73% | +4.8% |
| Q4 2020 | $41,311,000 | +1.5% | 2,000,000 | 0.0% | 0.69% | -29.3% |
| Q3 2020 | $40,702,000 | – | 2,000,000 | – | 0.98% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
| Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
| Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
| Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
| GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
| Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
| PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
| DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
| Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
| Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |